Table 5.
Long-term follow-up data
| Variable | Methyl-Pd (n = 39) | IVIg (n = 38) | p value |
|---|---|---|---|
| Maintenance of response at 1 year | 14/30 (46.7) | 15/29 (51.7) | 0.698 |
| Refractory state at 1 year | 2/30 (6.7) | 1/29 (3.4) | 0.574 |
| Maintenance of response at 2 years | 10/28 (35.7) | 12/26 (46.2) | 0.435 |
| Refractory state at 2 years | 2/28 (7.1) | 1/26 (3.8) | 0.597 |
| Maintenance of response at 5 years | 7/18 (38.9) | 5/14 (35.7) | 0.854 |
| Refractory state at 5 years | 3/18 (16.7) | 2/14 (14.3) | 0.854 |
| Loss of CR or R | 20/30 (66.7) | 18/33 (54.5) | 0.326 |
| Time to loss of CR or R, mon | 6.5 (2–72) | 3.5 (0.5–44) | 0.243 |
| Salvage therapy | 19 (50.0) | 18 (46.2) | 0.736 |
Values are presented as number (%) or median (range).
Methyl-Pd, methylprednisolone; IVIg, intravenous immune globulin; CR, complete response; R, response.